This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor. —
As reported in Pediatrics, Bisgaard et al1 compared safety and efficacy of fluticasone propionate and sodium cromoglycate in 1- to 3-year-old preschool children with mild to moderate recurrent wheeze in a randomized, parallel-group, open-label, 1-year-long study. They concluded that 100 μg of fluticasone propionate twice daily in these children had no effect on growth and no other important clinical side effect but was more efficacious than sodium cromoglycate. Although we acknowledge the importance of …
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Purchase access
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.